Friday, May 9, 2008, I bought my first shares of Onyx Pharmaceuticals. Since I have been writing about Onyx for a while, and intend to continue to write about the company, this is just a disclosure to my readers.
I consider Onyx to be promising but risky. My initial position is a small fraction of my small portfolio.
To see all my writing on Onyx, including my summaries of past analyst conferences, go to my main Onyx page.